Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Staedtler

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Mutation Research|November 16, 2004
Induction of A:T to G:C transition mutations by 5-(2-chloroethyl)-2'-deoxyuridine (CEDU), an antiviral pyrimidine nucleoside analogue, in the bone marrow of Muta MouseFrank Staedtler, Willi Suter, Hans-Joerg Martus
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|July 22, 2006
Characterisation of two rat mammary tumour models for breast cancer research by gene expression profilingHeike Marxfeld, Frank Staedtler, Johannes H Harleman
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 15, 2006
Gene expression in fibroadenomas of the rat mammary gland in contrast to spontaneous adenocarcinomas and normal mammary glandHeike Marxfeld, Frank Staedtler, Johannes H Harleman
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 15, 2006
Differentiation of spontaneous and induced mammary adenocarcinomas of the rat by gene expression profilingHeike Marxfeld, Olivier Grenet, Josiane Bringel, et al.
Toxicologic Pathology|December 25, 2003
Toxicogenomics in drug developmentNelson Guerreiro, Frank Staedtler, Olivier Grenet, et al.
Drug Discovery Today|April 24, 2012
The virtuous technology cycle concept and its application in next-generation sequencingYing Pluess-Li, Sandrine Bongiovanni, Edward J Oakeley, et al.
Mutation Research|November 16, 2004
Induction of gene mutations by 5-(2-chloroethyl)-2'-deoxyuridine (CEDU), an antiviral pyrimidine nucleoside analogueWilli Suter, Ulla Plappert-Helbig, Susanne Glowienke, et al.
Environmental Health Perspectives|May 26, 2004
Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway ratsJanine Ezendam, Frank Staedtler, Jeroen Pennings, et al.
Plos One|November 24, 2011
Optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex clinical blood samplesTing Gong, Nicole Hartmann, Isaac S Kohane, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 9, 2013
Robust and tissue-independent gender-specific transcript biomarkersFrank Staedtler, Nicole Hartmann, Martin Letzkus, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Mutation Research|November 16, 2004
Induction of A:T to G:C transition mutations by 5-(2-chloroethyl)-2'-deoxyuridine (CEDU), an antiviral pyrimidine nucleoside analogue, in the bone marrow of Muta MouseFrank Staedtler, Willi Suter, Hans-Joerg Martus
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|July 22, 2006
Characterisation of two rat mammary tumour models for breast cancer research by gene expression profilingHeike Marxfeld, Frank Staedtler, Johannes H Harleman
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 15, 2006
Gene expression in fibroadenomas of the rat mammary gland in contrast to spontaneous adenocarcinomas and normal mammary glandHeike Marxfeld, Frank Staedtler, Johannes H Harleman
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 15, 2006
Differentiation of spontaneous and induced mammary adenocarcinomas of the rat by gene expression profilingHeike Marxfeld, Olivier Grenet, Josiane Bringel, et al.
Toxicologic Pathology|December 25, 2003
Toxicogenomics in drug developmentNelson Guerreiro, Frank Staedtler, Olivier Grenet, et al.
Drug Discovery Today|April 24, 2012
The virtuous technology cycle concept and its application in next-generation sequencingYing Pluess-Li, Sandrine Bongiovanni, Edward J Oakeley, et al.
Mutation Research|November 16, 2004
Induction of gene mutations by 5-(2-chloroethyl)-2'-deoxyuridine (CEDU), an antiviral pyrimidine nucleoside analogueWilli Suter, Ulla Plappert-Helbig, Susanne Glowienke, et al.
Environmental Health Perspectives|May 26, 2004
Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway ratsJanine Ezendam, Frank Staedtler, Jeroen Pennings, et al.
Plos One|November 24, 2011
Optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex clinical blood samplesTing Gong, Nicole Hartmann, Isaac S Kohane, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 9, 2013
Robust and tissue-independent gender-specific transcript biomarkersFrank Staedtler, Nicole Hartmann, Martin Letzkus, et al.
Pageof 4